MedTrace Logo

Sonoclot to Evaluate Thrombotic Risk in Proteinuric Pregnancy

NCT05108389 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 13

Last updated 2023-04-06

No results posted yet for this study

Summary

There is a lack of consensus on whether women with proteinuric kidney disease benefit from prophylactic anticoagulation during pregnancy to reduce the risk of venous thromboembolism.

This pilot study will investigate the feasibility of obtaining thrombosis profile data using a viscoelastic haemostasis monitor - Sonoclot - from pregnant women with kidney disease, and exploratory analyses to elucidate correlations between output values and clinical parameters

Conditions

  • Pregnancy Complications
  • Proteinuria in Pregnancy
  • Chronic Kidney Diseases
  • Venous Thromboembolism

Interventions

DIAGNOSTIC_TEST

Viscoelastic haemostasis monitor output

Observational

Sponsors & Collaborators

  • Nottingham University Hospitals NHS Trust

    lead OTHER

Principal Investigators

  • Matthew Hall, MB MD FRCP · Nottingham University Hospitals

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-01
Primary Completion
2023-07-01
Completion
2023-10-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05108389 on ClinicalTrials.gov